Title | Type | SJR | H index | Total Docs. (2000) | Total Docs. (3years) | Total Refs. (2000) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2000) | %Female (2000) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
97 | BMC Immunology | journal | 73 | 1 | 0 | 35 | 0 | 0 | 0.00 | 35.00 | 75.00 | ||
96 | Clinical and Applied Immunology Reviews | journal | 20 | 10 | 0 | 614 | 0 | 0 | 0.00 | 61.40 | 36.36 | ||
95 | Current Opinion in Anti-inflammatory and Immunomodulatory Investigational Drugs | journal | 5 | 35 | 0 | 2174 | 0 | 0 | 0.00 | 62.11 | 23.53 | ||
94 | Developments in Biologicals | journal | 41 | 55 | 0 | 364 | 0 | 0 | 0.00 | 6.62 | 35.00 | ||
93 | Immunology. Supplement | journal | 0.110 Q4 | 0 | 0 | 2 | 0 | 0 | 2 | 0.00 | 0.00 | 0.00 | |
92 | Immunotechnology | journal | 1.178 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
91 | Inflamacion y Regulacion del Crecimiento Celular | journal | 0.100 Q4 | 1 | 0 | 38 | 0 | 0 | 37 | 0.00 | 0.00 | 0.00 | |
90 | International Journal of Immunopharmacology | journal | 0.350 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
89 | Journal of Lipid Mediators and Cell Signalling | journal | 0.456 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
88 | Nature Immunology | journal | 440 | 113 | 0 | 3729 | 0 | 0 | 0.00 | 33.00 | 32.90 | ||
87 | Research in Immunology | journal | 0.615 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
86 | Research in Virology | journal | 0.416 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
85 | Opportunistic Pathogens | journal | 0.120 Q4 | 4 | 0 | 25 | 0 | 3 | 23 | 0.00 | 0.00 | 0.00 | |
84 | Clinical and Experimental Allergy Reviews | journal | 0.398 Q3 | 17 | 0 | 5 | 0 | 7 | 5 | 1.75 | 0.00 | 0.00 | |
83 | International Journal of Thymology | journal | 0.118 Q4 | 5 | 0 | 43 | 0 | 7 | 42 | 0.00 | 0.00 | 0.00 | |
82 | Journal of Clinical and Laboratory Immunology | journal | 0.178 Q4 | 13 | 0 | 18 | 0 | 7 | 18 | 0.20 | 0.00 | 0.00 | |
81 | Arbeiten aus dem Paul-Ehrlich-Institut (Bundesamt fur Sera und Impfstoffe) Langen | journal | 0.146 Q4 | 10 | 0 | 67 | 0 | 8 | 67 | 0.00 | 0.00 | 0.00 | |
80 | Arthritis Research and Therapy | journal | 0.300 Q4 | 177 | 123 | 21 | 2901 | 11 | 10 | 0.52 | 23.59 | 30.11 | |
79 | Immunological Medicine | journal | 22 | 81 | 196 | 976 | 14 | 196 | 0.04 | 12.05 | 15.28 | ||
78 | Thymus | journal | 0.437 Q3 | 7 | 0 | 12 | 0 | 14 | 10 | 0.00 | 0.00 | 0.00 | |
77 | Current Directions in Autoimmunity | book series | 0.658 Q3 | 38 | 10 | 12 | 870 | 16 | 12 | 1.33 | 87.00 | 16.67 | |
76 | EOS Rivista di Immunologia ed Immunofarmacologia | journal | 0.126 Q4 | 5 | 19 | 59 | 1135 | 16 | 57 | 0.25 | 59.74 | 35.56 | |
75 | Bailliere's Clinical Infectious Diseases | journal | 0.288 Q4 | 8 | 0 | 51 | 0 | 21 | 46 | 0.48 | 0.00 | 0.00 | |
74 | Human Antibodies | journal | 0.243 Q4 | 28 | 6 | 48 | 143 | 30 | 48 | 0.35 | 23.83 | 43.75 | |
73 | Reviews in Immunogenetics | journal | 0.399 Q3 | 32 | 47 | 27 | 4218 | 31 | 27 | 1.15 | 89.74 | 28.37 | |
72 | International Journal of Immunotherapy | journal | 0.178 Q4 | 12 | 9 | 64 | 257 | 33 | 64 | 0.63 | 28.56 | 27.78 | |
71 | Natural Immunity | journal | 0.430 Q3 | 18 | 0 | 33 | 0 | 33 | 32 | 0.52 | 0.00 | 0.00 | |
70 | Inflammopharmacology | journal | 0.161 Q4 | 68 | 25 | 96 | 962 | 38 | 96 | 0.41 | 38.48 | 19.44 | |
69 | Pediatric Allergy and Immunology, Supplement | journal | 0.800 Q2 | 28 | 11 | 22 | 270 | 42 | 20 | 1.43 | 24.55 | 39.13 | |
68 | Nematologica | journal | 0.228 Q4 | 21 | 0 | 84 | 0 | 43 | 83 | 0.55 | 0.00 | 0.00 | |
67 | Food and Agricultural Immunology | journal | 0.227 Q4 | 43 | 26 | 94 | 560 | 47 | 94 | 0.48 | 21.54 | 34.33 | |
66 | International Journal of Tissue Reactions | journal | 0.339 Q3 | 27 | 15 | 42 | 468 | 48 | 42 | 1.09 | 31.20 | 35.00 | |
65 | Mycoses, Supplement | journal | 0.218 Q4 | 26 | 26 | 101 | 661 | 48 | 100 | 0.41 | 25.42 | 34.78 | |
64 | Innate Immunity | journal | 0.203 Q4 | 78 | 51 | 208 | 1626 | 64 | 195 | 0.16 | 31.88 | 23.78 | |
63 | Genes and Immunity | journal | 0.727 Q2 | 108 | 60 | 24 | 2164 | 65 | 23 | 2.71 | 36.07 | 31.41 | |
62 | Aerobiologia | journal | 0.275 Q4 | 57 | 74 | 130 | 1061 | 75 | 123 | 0.47 | 14.34 | 53.85 | |
61 | Cellular Microbiology | journal | 1.367 Q1 | 157 | 57 | 25 | 2643 | 79 | 25 | 3.16 | 46.37 | 38.81 | |
60 | Comparative Immunology, Microbiology and Infectious Diseases | journal | 0.418 Q3 | 65 | 24 | 91 | 628 | 81 | 91 | 0.92 | 26.17 | 28.24 | |
59 | International Journal of Immunopathology and Pharmacology | journal | 0.217 Q4 | 65 | 24 | 142 | 758 | 87 | 142 | 1.24 | 31.58 | 32.50 | |
58 | Archivum Immunologiae et Therapiae Experimentalis | journal | 0.209 Q4 | 72 | 73 | 170 | 3597 | 102 | 169 | 0.65 | 49.27 | 43.60 | |
57 | Clinical and Experimental Immunology, Supplement | journal | 2.611 Q1 | 23 | 0 | 13 | 0 | 102 | 13 | 16.00 | 0.00 | 0.00 | |
56 | Fundamental and Applied Nematology | journal | 0.267 Q4 | 36 | 0 | 148 | 0 | 103 | 146 | 0.73 | 0.00 | 0.00 | |
55 | Journal of Biological Regulators and Homeostatic Agents | journal | 0.415 Q3 | 56 | 53 | 95 | 1189 | 104 | 93 | 0.81 | 22.43 | 41.91 | |
54 | Allergy: European Journal of Allergy and Clinical Immunology, Supplement | journal | 0.497 Q3 | 49 | 41 | 117 | 1205 | 107 | 113 | 0.95 | 29.39 | 23.81 | |
53 | British Journal of Biomedical Science | journal | 0.264 Q4 | 48 | 52 | 138 | 1275 | 113 | 119 | 0.68 | 24.52 | 33.85 | |
52 | Journal of Medical and Veterinary Mycology, Supplement | journal | 1.213 Q1 | 27 | 0 | 32 | 0 | 123 | 32 | 3.84 | 0.00 | 0.00 | |
51 | Immunopharmacology and Immunotoxicology | journal | 0.311 Q3 | 61 | 45 | 128 | 1523 | 129 | 128 | 0.95 | 33.84 | 35.48 | |
50 | Medical Microbiology and Immunology | journal | 0.668 Q2 | 72 | 21 | 87 | 544 | 142 | 87 | 1.64 | 25.90 | 27.45 | |
49 | Cytokines, Cellular and Molecular Therapy | journal | 0.626 Q3 | 28 | 29 | 82 | 1099 | 145 | 81 | 1.67 | 37.90 | 22.77 | |
48 | Rheumatology International | journal | 0.473 Q3 | 89 | 40 | 114 | 879 | 157 | 109 | 1.26 | 21.98 | 31.10 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®